Stromal-epithelial interactions influence prostate cancer cell invasion by altering the balance of metallopeptidase expression.
about
Spotlight on valsartan-sacubitril fixed-dose combination for heart failure: the evidence to dateProtein profiling of isolated leukocytes, myofibroblasts, epithelial, Basal, and endothelial cells from normal, hyperplastic, cancerous, and inflammatory human prostate tissues.Identification of secreted glycoproteins of human prostate and bladder stromal cells by comparative quantitative proteomics.Role of the endothelin axis and its antagonists in the treatment of cancerNeuropeptide-inducible upregulation of proteasome activity precedes nuclear factor kappa B activation in androgen-independent prostate cancer cells.Targeting the endothelin system: novel therapeutic options in gynecological, urological and breast cancers.Endothelin-converting enzyme-1 (ECE-1) is post-transcriptionally regulated by alternative polyadenylationThe endothelin axis in head and neck cancer: a promising therapeutic opportunity?Angiotensin receptor neprilysin inhibitor LCZ696: pharmacology, pharmacokinetics and clinical development.In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies.Herpesvirus saimiri-based endothelin-converting enzyme-1 shRNA expression decreases prostate cancer cell invasion and migration.ECE-1 influences prostate cancer cell invasion via ET-1-mediated FAK phosphorylation and ET-1-independent mechanisms.Isoforms of endothelin-converting enzyme-1 (ECE-1) have opposing effects on prostate cancer cell invasion.Neutral endopeptidase inhibits prostate cancer tumorigenesis by reducing FGF-2-mediated angiogenesis.Endothelin-1 stimulates motility of head and neck squamous carcinoma cells by promoting stromal-epithelial interactions.
P2860
Q28070064-B2790501-503A-4E9B-BF5B-D341B7D5D7DDQ33692942-72AEB6CE-0EA6-43A3-ADCA-328F7CB79C0EQ34802793-C4FCC987-C8C2-4936-B18E-1DC889769A10Q34919570-ECD6A4D4-B8F9-42BE-8152-5C0ED60B73A9Q36233076-FE4F9709-55BA-4B47-930B-0044BF5FB339Q37256842-A01B7E8E-7F6E-4502-B903-4FB0F66AD1BDQ37537948-B0AE8D38-393B-400D-A02F-3856B6F51106Q38129921-DD836A89-9002-4017-8820-006DB75DE3C9Q38790076-6036CD64-5C0E-4035-B732-44E2D40A835AQ38925590-754C88C3-AF37-419B-ADB7-459EE8C6DB16Q39643724-FAEAFE2D-562C-48FF-B594-50B2861D309BQ39665344-2A0AAE5C-1AAC-4DBA-8679-6EA2892D2E0CQ39941689-BF4104B0-397C-4CE5-882D-F0F2CC0B59FBQ50677481-B284CBCC-EA17-4E3D-B639-A100F13BDE23Q54377971-DF15753E-6A1D-4C25-9E8A-09A52D8ACE39
P2860
Stromal-epithelial interactions influence prostate cancer cell invasion by altering the balance of metallopeptidase expression.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Stromal-epithelial interaction ...... f metallopeptidase expression.
@en
type
label
Stromal-epithelial interaction ...... f metallopeptidase expression.
@en
prefLabel
Stromal-epithelial interaction ...... f metallopeptidase expression.
@en
P2093
P2860
P356
P1476
Stromal-epithelial interaction ...... f metallopeptidase expression.
@en
P2093
A J Turner
B A Usmani
L A Dawson
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601717
P407
P577
2004-04-01T00:00:00Z
P5875
P6179
1038018473